Changes in immune and endocrine systems in posttraumatic stress disorder - prospective study

Area of Science:

• Endocrinology
• Immunology
• Psychiatry

Background:

• Posttraumatic stress disorder (PTSD) is linked to higher rates of autoimmune and cardiovascular diseases.
• Endocrine and immune system dysregulation are believed to mediate this increased medical morbidity.
• Understanding these physiological changes over time is crucial for managing PTSD comorbidities.

Purpose of the Study:

• To investigate longitudinal changes in hormonal levels (cortisol, prolactin) in PTSD patients.
• To assess alterations in proinflammatory cytokines (interleukin-6, tumor necrosis factor-alpha) and HPA-axis components (glucocorticoid receptor expression).
• To evaluate changes in immune function (natural killer cell cytotoxicity) and lymphocyte subpopulations over time.

Main Methods:

• Longitudinal assessment of patients diagnosed with PTSD.
• Measurement of serum cortisol, prolactin, interleukin-6, and tumor necrosis factor-alpha.
• Analysis of lymphocyte glucocorticoid receptor expression and natural killer cell cytotoxicity.
• Flow cytometry to determine percentages of T cells, helper T cells, cytotoxic T cells, B cells, and natural killer cells.

Main Results:

• Significant temporal changes were observed in cortisol and prolactin levels.
• Proinflammatory cytokine levels (IL-6, TNF-α) showed dynamic alterations.
• Modulations in glucocorticoid receptor expression and natural killer cell activity were detected.
• Shifts in the percentages of lymphocyte subpopulations, including T cells and B cells, were documented over the study period.

Conclusions:

• PTSD is associated with dynamic changes in the endocrine and immune systems over time.
• These longitudinal alterations in hormones, cytokines, and immune cells may contribute to the increased medical morbidity seen in PTSD.
• Further research is warranted to explore therapeutic interventions targeting these physiological pathways.